Prostatic recurrences in the management of superficial bladder tumors.
Mitomycin C has proved to be useful as prophylaxis against superficial bladder tumor recurrences. However, there is a significant incidence of prostatic urethral recurrences. Careful followup with urine cytology and cystoscopy, and bladder and prostatic urethral biopsies should be done at regular intervals.
D000328:Adult; D000368:Aged; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D002295:Carcinoma, Transitional Cell / Q000517:prevention & control* / Q000556:secondary; D006801:Humans; D008297:Male; D008875:Middle Aged; D016685:Mitomycin; D008937:Mitomycins / Q000627:therapeutic use*; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control*; D011471:Prostatic Neoplasms / Q000556:secondary; D014523:Urethral Neoplasms / Q000556:secondary*; D001749:Urinary Bladder Neoplasms / Q000517:prevention & control*
D000903:Antibiotics, Antineoplastic; D008937:Mitomycins; D016685:Mitomycin